Approval · Notice of Compliance 34568 · 2024
PEXEGRA: Notice of Compliance 34568
Issued December 13, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34568
- Date
- December 13, 2024
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- NEULASTA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEXEGRA | 02553945 | Marketed |
Medicinal ingredients
- PEGFILGRASTIM 10 MG per ML